News

The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
Among the eight people Robert F. Kennedy Jr. announced would make up his new group of outside vaccine advisers to the US ...
The safety of approved mRNA vaccines is well-established and, as with other vaccines, continues to be monitored by multiple ...
Kennedy’s decision to “retire” the previous 17-member panel was widely decried by doctors’ groups and public health ...
Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID ...
Moderna's mNexspike COVID vaccine approved by FDA for older adults and at-risk groups after Phase 3 trial shows improved ...
Three of the health secretary’s picks to replace fired members of an influential panel that sets U.S. vaccine policies have ...
Researchers have developed a new mRNA vaccine that overcomes the challenges associated with current mRNA therapeutic ...
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump administration vs. mRNA vaccines ...